Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-22

Clinical Trial Update: rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance [EARLY_Phase 1]

View source ↗

Summary

An early-phase study evaluating rhPSMA-73 PET-MRI imaging to detect prostate cancer in men considered for active surveillance; the trial is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • rhPSMA-73

Snippet

Sponsor: Northwestern University | Conditions: Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8 | EARLY_Phase 1 | Status: RECRUITING